IPO - Xtant Medical Holdings, Inc.

Form Type: S-1

Filing Date: 2025-05-12

Corporate Action: Ipo

Type: New

Accession Number: 000164117225009734

Filing Summary: Xtant Medical Holdings, Inc. has filed a registration statement on Form S-1 with the SEC for the resale of 73,114,592 shares of common stock by selling stockholders, derived from a private sale on April 10, 2025, with an offering price of $0.42 per share. This filing is part of a shelf registration process, allowing the selling stockholders to sell these shares over time after the registration statement becomes effective. The company will not receive any proceeds from this sale, nor will it be selling any of its own shares. The focus of the offering is to facilitate liquidity for the selling stockholders while managing the impact on the market, particularly given the large volume of shares representing about 52.5% of the company's common stock. The common stock is currently traded on the NYSE American under the symbol 'XTNT' with a reported price of $0.54 per share as of May 8, 2025. Investors are warned of risks associated with this stock, including volatility and delisting risks due to low trading prices. Summary risk factors suggest market fluctuations, capital raising challenges, potential litigation, and general market conditions could significantly impact stock prices and overall investment outcomes.